Navigation Links
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
Date:7/31/2008

e Deputy Chairman.

- On July 1, 2008 Graham Hetherington joined Shire as Chief

Financial Officer and Executive Board Director. Graham Hetherington has

a broad range of experience in senior financial roles having most

recently held positions as Chief Financial Officer of Bacardi (2007)

and Allied Domecq plc (1999-2005).

- On April 24, 2008 Shire announced that Michael Rosenblatt

M.D. joined the Shire Board as a Non-Executive Director.

- On July 29, 2008 Robin Buchanan, due to his other

commitments, stepped down from the Shire Board on the completion of his

term of office.

Dividend

In respect of the six months ended June 30, 2008, the Board resolved to pay an interim dividend of 2.147 US cents per ordinary share (2007: 2.147 US cents per share).

Dividend payments will be made in Pounds Sterling to Ordinary shareholders and in US Dollars to holders of American Depository Shares ("ADSs"). A dividend of 1.085 pence per ordinary share (2007: 1.048 pence) and 6.441 US cents per ADS (2007: 6.441 US cents) will be paid on October 9, 2008 to persons whose names appear on the register of members of the Company at the close of business on September 12, 2008.

As previously disclosed Shire intends to put in place Income Access Share arrangements enabling shareholders to choose whether they receive their dividends from a company resident for tax purposes in the Republic of Ireland or from a company resident for tax purposes in the United Kingdom. The arrangements will be in place for the interim dividend. In accordance with the Shire ADS Deposit Agreement, the ADS Depositary will make an election on behalf of all holders of ADSs to receive UK sourced dividends. Details of the Income Access Share arrangements can be found in the Scheme Circular issued on April 16, 2008, which is available on the Company's website http://www.shire.com<
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...or Arrowhead’s 2010 Personalized Medicine Pa...on February 22-24, 2010 in Philadelphia, has been ...ghlight key issues in forming partnerships and eng... , Minneapolis, MN (PRWEB)...o;s 2010 Personalized Medicine Partnerships Confe...
(Date:11/5/2009)...rstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: ...dent and CEO of Imagenetix, will be presenting the...ence on Thursday, December 3rd, at 10:30 AM PST at...CRO ,, LD MICRO is a by-invitation only newslet...nies in the micro-cap space. Since 2002, the firm ...
(Date:11/5/2009)...swire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today... the following investor conferences, and invited i... Credit Suisse Healthcare Conference, Phoeni... at 10 a.m. Mountain Time, NASDAQ... Tuesday, 1 December, 2009 at 10.45 a.m....
(Date:11/5/2009)...5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corp...ompany") today announced,that the Company plans to...onday, November 9, 2009, after the market closes. ... at 5:00 pm ET on November 9, 2009,to discuss thir...call by,dialing 1-888-713-4211 or 1-617-213-4864 f...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...y, LLC announced,today that two new managing direc...firm in July 2007 as Managing Director and,Associa...uates the,intellectual property portfolios of pote...works in tandem with current investment companies ...perty positions. Mr. Perez,joined Third Security f...
... forward in Phase III development, NEW YORK, Aug.... licensing agreement for acadesine with Schering-P...ent grants Schering-Plough exclusive,worldwide rig...eriCor,s,lead compound, acadesine. Financial terms... is currently under evaluation in Phase III clinic...
...nter for Molecular,Medicine (CMM) today said it wa...ursing mothers for codeine risks cited in a Friday...(FDA). Late Friday, the FDA issued an advisory no...s, side effect in nursing infants whose mothers ar...zers of that drug. The FDA,advisory recommended ph...
Other Biology Technology:Third Security, LLC Hires Two New Managing Directors 2PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation 2PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation 3Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers 2
(Date:11/4/2009)... out, hold the power to help militaries and muniti... toxic waste on test sites. , Compounds known as...in World War II and have been used in military mun...re often used to propel tank shells and act like a...eased knowledge of their environmentally harmful e...
(Date:11/4/2009)...swire/ -- DigitalPersona, Inc., a leader in finger... announced that WAND Corporation, a leading suppli...ce restaurants, has integrated DigitalPersona tech...tions. WAND,s quick-service customers can now use ...lity and deter unauthorized manager overrides. A...
(Date:11/4/2009)...obal Rainmakers, Inc., an intellectual property ho...ay announced that the company has exited its "stea...e its suite of technologies designed to leverage c...ring the past four years, the company has spent te...series of core--but expandable--technologies built...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3CRGT Sponsors Teardrops to Rainbows Golf Tournament 56541 1CRGT Sponsors Teardrops to Rainbows Golf Tournament 56541 2Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 1Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 2Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 3Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 4NephroGenex Announces Full Enrollment in New Pyridorin 28TM 29 Clinical Trial PYR 210 56533 1NephroGenex Announces Full Enrollment in New Pyridorin 28TM 29 Clinical Trial PYR 210 56533 2
...olecular Biology Organization (EMBO) announced tha...m the University of Konstanz, Germany, will receiv...e Sciences. EMBO awards the prize annually to a pr...nication with the public. Axel Meyer receives the ...o convey complex scientific topics to the general ...
...iversity of Rochester,s Eastman School of Music an...developed a unique test for perfect pitch, and hav... that perfect pitchthe ability to recognize and re...h more common in non-musicians than scientists had...ople because without extensive musical training it...
...ust 25, 2008Borrowing and sharing of prescription ... concern. A survey of nearly 7,500 women of repro...ng more than one-third of this population, accordi... Journal of Women,s Health , a peer-reviewed journ...s available free online at http://www.liebertonli...
Other Biology News:Prominent German biologist wins EMBO Communication Award 2'Perfect pitch' in humans far more prevalent than expected 2'Perfect pitch' in humans far more prevalent than expected 3Trends in prescription medication sharing among reproductive-aged women 2
MoDC Cell Chip-IHC from 3H Biomedical AB
Isotetrandrine from Calbiochem
...ipetting is increasingly essential for reducing sa... biochemical applications. The eight-channel nano2...eled in the industry. ,Features: , Real-time doc...d volumes , Automated diagnostics detect and corre...
Microtiter Wells from Bethyl Laboratories
Biology Products: